Similar Search Results

Diffusion of health technologies : evidence from the pharmaceutical sector

Serra-Sastre, Victoria; McGuire, Alistair - In: The economics of new health technologies : incentives, …, (pp. 53-71). 2009

Persistent link: https://www.econbiz.de/10003915931

Regulation effects on the adoption of new medicines

Costa-Font, Joan; McGuire, Alistair; Varol, Nebibe - In: Empirical economics : a journal of the Institute for … 49 (2015) 3, pp. 1101-1121

Persistent link: https://www.econbiz.de/10011377336

Does adoption of pharmaceutical innovation respond to changes in the regulatory environment?

Varol, Nebibe; Costa-Font, Joan; McGuire, Alistair - In: Applied economic perspectives and policy 34 (2012) 3, pp. 531-553

Persistent link: https://www.econbiz.de/10009721541

The determinants of access to health care and medicines in India

Srivastava, Divya; McGuire, Alistair - In: Applied economics 48 (2016) 16/18, pp. 1618-1632

Persistent link: https://www.econbiz.de/10011456704

Does Pharmaceutical Price Regulation Affect the Adoption of Generic Competition? Evidence from the OECD, 1999-2008

Varol, Nebibe - 2014

Generic competition in the pharmaceutical market is an effective cost-containment mechanism that improves static efficiency and stimulates pharmaceutical innovation. There is no prior study that has empirically analysed the relative delays in adoption of generic competition. This paper aims to...

Persistent link: https://www.econbiz.de/10013068052